Navigation Links
BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
Date:5/1/2012

LUND, Sweden, May 1, 2012 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today that it has been selected as a Top 100 Winner for Red Herring's 2012 Europe Award, a prestigious list honoring the year's most promising private technology ventures from the European business region.  BONESUPPORT was one of only nine winners within the healthcare categories.

(Photo: http://photos.prnewswire.com/prnh/20120501/NY96596 )

"Choosing the companies with the strongest potential was by no means a small feat," said Alex Vieux, publisher and CEO of Red Herring. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across Europe to the Top 100 Winners.  We believe BONESUPPORT embodies the vision, drive and innovation that define a successful entrepreneurial venture.  BONESUPPORT should be proud of its accomplishment, as the competition was the strongest it has ever been."

The Red Herring editorial team selected a short list of 247 companies to compete as 2012 winners after assessing the most innovative companies from a pool of hundreds from across Europe.  The Top 100 Europe winners were evaluated on quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and disruption in their respective industries.

This unique assessment of potential is complemented by a review of the actual track record and standing of a company, which allows Red Herring to see past the 'buzz' and make the list a valuable instrument for discovering and advocating the greatest business opportunities in the industry.

"Our business has recently shifted from a research and development focus to a fully commercial and multi channeled business," said Lloyd Diamond, CEO of BONESUPPORT. "I am pleased that our efforts and our innovative technology have been recognized in this way.  As one of only nine companies within the Healthcare categories to win an award, we are extremely proud." 

For more information about BONESUPPORT and CERAMENT, visit www.BONESUPPORT.com.

About Red Herring

Red Herring is a global media company uniting the world's best high-technology innovators, venture investors, and business decision-makers in a variety of forums:  a leading innovation magazine, an online daily technology news service technology newsletters, and major events for technology leaders around the globe.  Red Herring provides an insider's view of the global innovation ecosystem, featuring unparalleled insights on the emerging technologies driving the economy.

About BONESUPPORT

BONESUPPORT is an emerging leader of injectable bone substitutes for orthopedic trauma focusing on bone infection, instrument augmentation related to orthopedic surgery and spinal applications. CERAMENT™ is a fully developed product platform that is commercially available in the U.S. and Europe and is revolutionizing the treatment of fragility and other fractures caused by disease and trauma. Scientific research of CERAMENT spans more than eleven years and over forty-five pre-clinical, clinical and animal studies have been conducted. More than 4,000 patients have been treated with CERAMENT.  The company was founded in 1999 and is based in Lund, Sweden with subsidiary locations in the US and Germany. To learn more about BONESUPPORT please visit www.bonesupport.com.

Press Inquiries:

Fredrik Groth, CFO, +46 46 286 53 60, Fredrik.Groth@bonesupport.com

 


'/>"/>
SOURCE BONESUPPORT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BONESUPPORTS New CEO Announces 100 Day Plan
2. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
3. Nephros Receives 510(k) Clearance for Hemodiafiltration System
4. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
5. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
6. Chromogenex Receives FDA Clearance for Circumferential Reduction for i-Lipo Body Contouring System
7. Qualitest Pharmaceuticals Receives FDA Approval for Levetiracetam Oral Solution, 100 mg/mL
8. American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9. Labcon Receives Renewal of Quality Certification
10. Roche Receives FDA Approval for cobas p 630 Pre-analytical Solution for Automated Molecular Testing Platform
11. MAP Pharmaceuticals Receives Complete Response Letter from FDA for LEVADEX® (dihydroergotamine) NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
Breaking Medicine News(10 mins):